Kourzeq Oral Paste launched for Canker Sore and oral inflammatory lesions

Written By : Jacinthlyn Sylvia |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2023-11-24T09:30:52+05:30 | Updated On 24 Nov 2023 12:18 PM IST

A new study released by the MidAmerica Pharmaceuticals unveiled a reasonable solution for the painful issue caused by canker sores with the launch of KOURZEQ™ (triamcinolone acetonide dental paste USP, 0.1%). This FDA-approved prescription oral paste is tailored to efficiently treat oral lesions, providing relief to individuals suffering from the discomfort of canker sores.

Canker sores, also known as the aphthous ulcers, are shallow lesions found around the soft tissues inside the mouth. KOURZEQ is formulated to accelerate the healing process by reducing inflammation, offering relief from burning sensations, and alleviating pain associated with canker sores.

A distinctive feature of KOURZEQ is its exclusive availability through telehealth services, made possible through a strategic partnership between MidAmerica Pharmaceuticals and BeyondMD®. Interested consumers can visit kourzeq.doctalkgo.com to set up a virtual consultation with a qualified healthcare professional. If deemed appropriate following the assessment, the prescription for KOURZEQ can be ordered and delivered directly to the patient's doorstep.

Eve del Rio, MD, Chief Medical Officer for MidAmerica Pharmaceuticals, expressed the company's commitment to providing a swift and effective remedy for canker sores. "We are pleased to be offering a new FDA-approved option for those living with, and suffering from, canker sores. We are confident that KOURZEQ will make a positive difference for those suffering from canker sores."

Linda Brennan, the MidAmerica Pharmaceuticals CEO added saying "After seeing firsthand how painful canker sores can be, I created MidAmerica Pharmaceuticals so that we can bring a solution to millions of people."

The telehealth distribution model aims to streamline the process of obtaining both expert healthcare advice and access to KOURZEQ. John Bernard, M.D., Medical Director for BeyondMD, emphasized the relief this will bring to canker sore sufferers.

Source:

Pharmaceuticals, M. (2023, November 14). MidAmerica Pharmaceuticals Launches KOURZEQTM Oral Paste - an FDA Approved Prescription Medication that Helps Canker Sores Heal Faster. MidAmerica Pharmaceuticals.

MidAmerica PharmaceuticalsCanker Soresdental Paste

Source : MidAmerica Pharmaceuticals

Jacinthlyn Sylvia

Neuroscience Masters graduate

Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751